Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

PYC Therapeutics, a developer of RNA therapies for genetic diseases and capitalised at $933 million on the ASX, confirmed a $653 million equity raising on Monday morning after Street Talk revealed the ...

PYC Therapeutics Ltd (ASX: PYC) has announced a massive $653 million capital raise to progress four of its drug candidates through human clinical trials. With PYC's value sitting at $944.8 million at ...

Game decompilations have been in the news on and off again for quite some time. It’s the act of reverse engineering games to run natively on PC (or any hardware, in theory). Now, there’s potential for ...

We feel now is a pretty good time to analyse PYC Therapeutics Limited's (ASX:PYC) business as it appears the company may be on the cusp of a considerable accomplishment. PYC Therapeutics Limited, a ...

A look at the shareholders of PYC Therapeutics Limited (ASX:PYC) can tell us which group is most powerful. The group holding the most number of shares in the company, around 45% to be precise, is ...

PYC Therapeutics has built a pipeline of drug candidates addressing rare genetic diseases, with three assets now in clinical stages. The company’s strategy centers on using RNA therapeutics to ...

Abstract: Python is one of the most popular programming languages among both industry developers and malware authors. Despite demand for Python decompilers, community efforts to maintain automatic ...